Literature DB >> 18471033

Managed care and cancer outcomes for Medicare beneficiaries with disabilities.

Richard G Roetzheim1, Thomas N Chirikos, Kristen J Wells, Ellen P McCarthy, Long H Ngo, Donglin Li, Reed E Drews, Lisa I Iezzoni.   

Abstract

OBJECTIVE: To determine if the type of insurance arrangement, specifically health maintenance organization (HMO) vs fee-for-service (FFS), affects cancer outcomes for Medicare beneficiaries with disabilities. STUDY
DESIGN: Retrospective cohort.
METHODS: We used the Surveillance, Epidemiology, and End Results-Medicare linked dataset to identify beneficiaries older and younger than 65 years entitled to Medicare benefits because of disability (Social Security Disability Insurance) who subsequently were diagnosed as having breast cancer (n = 6839) or non-small cell lung cancer (n = 10,229) from 1988 through 1999. We categorized persons according to Medicare insurance arrangement (continuous FFS, continuous HMO, or mixed FFS/HMO) during the periods 12 months before diagnosis and 6 months after diagnosis. Using a retrospective cohort design, we examined stage at diagnosis, cancer-directed treatments, and survival.
RESULTS: Women with continuous HMO insurance had earlier-stage breast cancer diagnosis (adjusted relative risk, 0.77; 95% confidence interval, 0.65-0.91) and were more likely to receive radiation therapy following breast-conserving surgery (adjusted relative risk, 1.11; 95% confidence interval, 1.03-1.19). Women having continuous HMO insurance had better breast cancer survival, primarily resulting from earlier-stage diagnosis. Among persons with non-small cell lung cancer, those having mixed FFS/HMO insurance were more likely to receive definitive surgery for early-stage disease (adjusted odds ratio, 1.23; 95% confidence interval, 1.02-1.49) and to have better overall survival but not significantly better lung cancer survival.
CONCLUSION: When diagnosed as having breast cancer or non-small cell lung cancer, some Medicare beneficiaries with disabilities fare better with managed care compared with FFS insurance plans.

Entities:  

Mesh:

Year:  2008        PMID: 18471033      PMCID: PMC4110639     

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  44 in total

1.  Medicare health maintenance organizations and traditional coverage: perceptions of health care among beneficiaries with disabilities.

Authors:  P W Beatty; K R Dhont
Journal:  Arch Phys Med Rehabil       Date:  2001-08       Impact factor: 3.966

2.  Preventive services among Medicare beneficiaries with supplemental coverage versus HMO enrollees, medicaid recipients, and elders with no additional coverage.

Authors:  O Carrasquillo; R A Lantigua; S Shea
Journal:  Med Care       Date:  2001-06       Impact factor: 2.983

3.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

4.  Breast cancer outcomes among older women: HMO, fee-for-service, and delivery system comparisons.

Authors:  A Lee-Feldstein; P J Feldstein; T Buchmueller; G Katterhagen
Journal:  J Gen Intern Med       Date:  2001-03       Impact factor: 5.128

Review 5.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).

Authors:  N P Rowell; C J Williams
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 6.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.

Authors:  N P Rowell; C J Williams
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

7.  Breast carcinoma treatment received by women with disabilities compared with women without disabilities.

Authors:  Mabel E Caban; Margaret A Nosek; Daniel Graves; Francisco J Esteva; Marsha McNeese
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

8.  Health care factors related to stage at diagnosis and survival among Medicare patients with colorectal cancer.

Authors:  Anna Lee-Feldstein; Paul J Feldstein; Thomas Buchmueller
Journal:  Med Care       Date:  2002-05       Impact factor: 2.983

9.  Use of SEER-Medicare data for measuring cancer surgery.

Authors:  Gregory S Cooper; Beth Virnig; Carrie N Klabunde; Nicola Schussler; Jean Freeman; Joan L Warren
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

10.  Studying radiation therapy using SEER-Medicare-linked data.

Authors:  Beth A Virnig; Joan L Warren; Gregory S Cooper; Carrie N Klabunde; Nicola Schussler; Jean Freeman
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

View more
  6 in total

1.  Disparities in short-term and long-term all-cause mortality among Korean cancer patients with and without preexisting disabilities: a nationwide retrospective cohort study.

Authors:  Sang Min Park; Ki Young Son; Jae-Hyun Park; Belong Cho
Journal:  Support Care Cancer       Date:  2011-04-26       Impact factor: 3.603

2.  Reach of the Montana Cancer Control Program to Women with Disabilities.

Authors:  Katherine Froehlich-Grobe; William C Shropshire; Heather Zimmerman; Jim Van Brunt; Andrea Betts
Journal:  J Community Health       Date:  2016-06

3.  Geographic disparities in late-stage cancer diagnosis: multilevel factors and spatial interactions.

Authors:  Lee R Mobley; Tzy-Mey May Kuo; Lisa Watson; G Gordon Brown
Journal:  Health Place       Date:  2012-06-26       Impact factor: 4.078

4.  Accuracy and complexities of using automated clinical data for capturing chemotherapy administrations: implications for future research.

Authors:  Erin J Aiello Bowles; Leah Tuzzio; Debra P Ritzwoller; Andrew E Williams; Tyler Ross; Edward H Wagner; Christine Neslund-Dudas; Andrea Altschuler; Virginia Quinn; Mark Hornbrook; Larissa Nekhlyudov
Journal:  Med Care       Date:  2009-10       Impact factor: 2.983

5.  Paying on the margin for medical care: Evidence from breast cancer treatments.

Authors:  Liran Einav; Amy Finkelstein; Heidi Williams
Journal:  Am Econ J Econ Policy       Date:  2016-02

Review 6.  From radical mastectomy to breast-conserving therapy and oncoplastic breast surgery: a narrative review comparing oncological result, cosmetic outcome, quality of life, and health economy.

Authors:  Ahmad Kaviani; Nassim Sodagari; Sara Sheikhbahaei; Vahid Eslami; Nima Hafezi-Nejad; Amin Safavi; Maryam Noparast; Alfred Fitoussi
Journal:  ISRN Oncol       Date:  2013-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.